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Abstract As examined by the luciferase assay, a negative regu- 
latory region including the NFKB motif was found in the S- 
flanking region of the 124ipoxygenase gene in human erythroleu- 
kemia cells. The negative control was abolished by a site-specific 
mutation of the NFKB motif. Probes including the NFKB region 
gave positive bands upon a gel-shift assay. The bands were super- 
shifted by antibodies for NFKB ~50, NFKB p65 and c-Rel, and 
were lost by a NFKB competitor DNA. Furthermore, the NFKB 
sequence was protected in DNase I footprinting. Thus, two kinds 
of heterodimer (~50 and ~65; ~50 and c-Rel) seemed to control 
the over-expression of the human 1Zlipoxygenase gene. 
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1. Introduction 
Lipoxygenase enzymes are dioxygenases which incorporate 
one molecule of oxygen at specific positions of unsaturated 
fatty acids. 12-Lipoxygenase oxygenates the 12-position of ara- 
chidonic acid, and produces regio- and stereo-specifically 
12(S)-hydroperoxy-5,8,10,14-eicosatetraenoic acid. There are 
two isoforms of 12-lipoxygenase which are distinguishable in 
terms of substrate chain length specificity, reactivity with anti- 
body, homology of their amino acid sequences and exon-intron 
structures of their genes [l]. When the genomic DNAs of 12- 
lipoxygenases of porcine leukocytes [2], human erythroleuke- 
mia (HEL) cells [3,4], murine platelets [5], and murine leuko- 
cytes [5] were cloned and sequenced, neither typical TATA box 
nor CCAAT box was found in their promoter regions, suggest- 
ing that the 12-lipoxygenase is a product of a housekeeping 
gene. SPl consensus sequences and also other regulatory ele- 
ments such as AP2 and NFlcB sites were present in the human 
12-lipoxygenase gene [3,4]. 
NFlcB was originally found as a binding protein to immuno- 
globulin IC light-chain enhancer [6]. Motifs for NFlcB have been 
found in many genes encoding immunoreceptors (immunoglob- 
ulin IC light chain and major histocompatibility complex class 
I), cytokines (interleukins-2 and -6 and tumor necrosis factor-a) 
and viral proteins (human immunodeficiency virus-l, cy- 
tomegalovirus and simian virus 40) [7-l 11. The NFlcB is now 
considered as a ubiquitous transcription factor. It is constitu- 
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tively present in the nuclei in B cells, certain T cell lines and 
monocytes, and has the structure of either homodimer or heter- 
odimer [S-11]. The heterodimer of ~50 and ~65 subunits has 
higher affinity to the NFKB site than the homodimer of either 
~50 or ~65 [12]. Moreover, Rel proteins were found as onco- 
gene products of reticuloendotheliosis virus strain T in turkey 
[13], and also has been shown to function as a transcription 
factor. The NFKB and Rel proteins are a family with high 
homologies in their amino acid sequences. 
In this study, we found that NFKB ~50 and ~65 or c-Rel 
heterodimers suppressed the over-expression of 12-lipoxyge- 
nase gene in HEL cells. This is the first demonstration of the 
NFlcB/Rel protein as a transcription factor regulating the gene 
expression of mammalian lipoxygenases. 
2. Materials and methods 
2. I. Cell culture of HEL cells 
The HEL cell line was kindly provided by Dr. Y. Eto of Ajinomoto 
Central Research Laboratories and Dr. S. Narumiya of Kyoto Univer- 
sity. The cells were cultured in RPM1 1640 medium (Gibco-BRL) con- 
taining 10% fetal calf serum (FCS) (Biological Industries) and strepto- 
mycin sulfate (100 mg/l) adjusted to pH 7.4 by the addition of sodium 
bicarbonate [14]. The cells were cultured at an initial density of 1 x lo5 
cells/ml in lOO-mm plastic dishes at 37°C in a humidified atmosphere 
of 7% CO, in air, and grown for 34 days to a density of 10-12 x lo5 
cells/ml. 
2.2. Construction of the luciferuse reporter vector 
DNA fragments of various lengths containing human 12-lipoxyge- 
nase promoter regions were prepared either by restriction enzyme diges- 
tion of the genomic clone for pXLO-01, 1, 3 and 4-1 or by the polym- 
erase chain reaction (PCR) amplification method for pXLO-4-2, 4-4, 
4-3, 5-1, 5-2, 5-3, 6 and 7. The PCR amplification was performed for 
25 cycles (94°C for 1 min, 55°C for 2 min, and 74°C for 2 min) using 
Pfu polymerase (Stratagene). The DNA fragments were ligated into a 
luciferase plasmid pXP-1 [15] as described by Sambrook et al. [16]. A 
mutant at the site of NFrcB (pXLO-NFMl) was constructed by the 
site-specific mutagenesis method as described by Higuchi et al. [17]. All 
the plasmids for transfection were purified by the use of Qiagen-tip 100 
(Qiagen) or by equilibrium centrifugation in CsCl/ethidium bromide 
gradients. 
2.3. Transfection of plasmids to HEL cells 
The lipofection method was performed using Lipofectamin (Gibco- 
BRL) according to the manufacturer’s instructions with a slight modi- 
fication. HEL cells (1 x 10’ cells/ml) were cultured up to a density of 
1 x lo6 cells/ml, harvested by pipetting, washed with RPM1 1640 me- 
dium without FCS and streptomycin sulfate, and resuspended in Opti- 
MEM medium (Gibco-BRL) at a density of 1.5 x lo6 cells/ml. The 
suspension (0.8 ml) was seeded in 35-mm plastic dishes. Lipofectamin 
(15 ~1) was incubated with 3 pg of pXL0 luciferase plasmid and 1 pg 
of pCMV /3-galactosidase plasmid (Clontech) in 200 ~1 of Opti-MEM 
medium in a CO> incubator for 30 min at 37°C. The mixture was added 
to the above-treated cells, followed by incubation for 20 h at 37°C in 
a humidified atmosphere of 7% CO,. RPM1 1640 medium with 10% 
FCS (4 ml) was added to the dishes, and the cells were incubated for 
additional 18 h. 
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2.4. Luciferase and B-galactosidase assays 
The luciferase activity was measured using the PicaGene luciferase 
assay system (Toy0 Ink Corporation). The 1.2 x lo6 transfected cells 
were harvested, washed with phosphate-buffered saline by centrifuga- 
tion, and resuspended in 40 ~1 of PicaGene lysis buffer. After a 15min 
incubation at room temperature, the suspension was centrifuged at 
12,000 rpm for 15 s, and the supernatant solution was used as the cell 
lysate. PicaGene luciferase assay substrates in 100 ~1 were mixed with 
20 ~1 of the cell lysate, and then the luciferase activity was measured 
by a Berthold Lumat LB 9501 luminometer. For /I-galactosidase assay, 
15 ~1 of the cell lysate were mixed with 285 ~1 of 0.1 M sodium phos- 
phate buffer at pH 7.5 containing 10 mM KCI, 1 mM MgCl,, 0.1% (v/v) 
Triton X-100 and 5 mM /I-mercaptoethanol, and the mixture was kept 
at 37°C for 10 min. The reaction was started by the addition of 50 ~1 
of o-nitrophenyl-/I-o-galactopyranoside solution (4 mg/ml in 0.1 M 
sodium phosphate buffer at pH 7.5) and continued for 2 hat 37°C. The 
reaction was stopped by the addition of 150 ~1 of 1 M Na,CO,, and 
absorbance at 420 nm was measured by a Beckman DU 640 spectro- 
photometer. The luciferase activities were normalized to the P-galacto- 
sidase activities, 
2.5. Preparations of nuclear extracts from HEL, U937 and HeLa cells 
Nuclear extracts were prepared as described by Dignam et al. [18] 
with a slight modification, HEL cells were grown to a density of 
1.5 x lo7 cells/IO ml in 100-mm plastic dishes. The cells from 20 dishes 
were collected (3 x 10’ cells), suspended in 5 ml of 10 mM HEPES at 
pH 7.9 containing 1.5 mM MgCl,, 10 mM KCI, 0.5 mM dithiothreitol, 
and 0.5 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma), incubated 
on ice for 10 min, and homogenized by a Dounce homogenizer B pestle. 
The cell homogenate was centrifuged at 1,000 x g for 10 min at 4°C 
and the pellet was suspended in 2 ml of 20 mM HEPES at pH 7.9 
containing 25% (v/v) glycerol, 0.5 M NaCI, 1.5 mM MgCl,, 0.2 mM 
EDTA, 0.5 mM dithiothreitol, 0.5 mM PMSF, 0.5 mg/ml pepstatin A 
(Peptide Institute), 0.5 mg/ml leupeptin (Peptide Institute), and 1.3 
pus/ml spermidine (Sigma). The suspension was stirred at 30 rpm for 1 h 
at 4°C and centrifuged at 100,000 x g for 30 min at 4°C. The resulting 
supernatant was dialyzed twice each for 12 h against 1.5 liter of 20 mM 
HEPES at pH 7.9 containing 20% (v/v) glycerol, 0.1 M KCl, 0.2 mM 
EDTA, 0.5 mM dithiothreitol, and 0.5 mM PMSF. The dialysate was 
centrifuged at 30,000 x g for 30 min at 4°C. The supernatant was stored 
at -80°C until use. U937 cells were grown to a density of 1.0x 10’ 
cells/l0 ml with RPM1 1640 medium and 10% FCS in lOO-mm plastic 
dishes. HeLa cells were grown to a density of 5 x lo6 cells/l0 ml with 
DMEM medium and 10% FCS in lOO-mm plastic dishes, and treated 
with 2.5 PM phorbol 12-myristate 13-acetate for 30 h. The nuclear 
extracts from U937 and HeLa cells were prepared as described above. 
2.6. DNase I footprinting analysis 
Two probes were prepared for the DNase I footprinting reaction. 
The probes were amplified by PCR method as described above for the 
luciferase reporter gene construction. We used two primers: upstream 
primer (-618 to -595), 5’-TCGTTGACGGAAGCACAGCGTTC-3’; 
downstream primer (-435 to -416) f-ATGAGTCCATCTTCCAA- 
ACG-3’. Either of the two primers was labeled with [Y-~*P]ATP (Du- 
Pont-NEN) using T4 polynucleotide kinase (New England Biolab). 
Amplified DNA fragments were purified electrophoretically on a 5% 
polyacrylamide gel, and used as sense and antisense probes. The DNase 
I footprinting reaction was performed as described by Roesler et al. 
[19]. DNA sequencing with the sense strand was carried out using 
Sequenase sequence system (U.S. Biochemical Corporation). G + A 
reaction was performed as described by Sambrook et al. [16]. These 
sequence ladders were used as reference. The reaction mixtures were 
denatured at 95°C for 5 min, and loaded onto an 8% polyacrylamide 
sequencing gel containing 8 M urea. The gel was dried and exposed to 
Kodak XAR film with an intensifying screen for three days at -80°C. 
2.7. Electrophoretic mobility-shift assay (EMSA) 
Two pairs of oligonucleotide targeting NFlcB site from -520 to -544 
bp were synthesized: oligo 1,5’-GCCGCGGGACATCCCCAGACC- 
CCAG-3’ and oligo 2,5’-CTGGGGTCTGGGGATGTCCCGCGGC- 
3’; oligo 3,5’-GCCGCGGCCCATCCCCAGACCCCAG-3’ and oiigo - 
4,5’-CTGGGGTCTGGGGATGGGCCGCGGC-3’. Oligo 3 and oligo 
4 were site-specific mutants for NFlcB motif (the underlined bases were 
changed). Each pair of oligonucleotide (oligo 1 and oligo 2, or oligo 3 
and oligo 4) was annealed as described by Berger and Kimmel [20]. 
Annealed oligonucleotides were isolated electrophoretically on a 15% 
polyacrylamide gel, end-labeled with [Y-~‘P]ATP, and used as probes 
(86 or 87, respectively). For competition analysis, an annealed oligonu- 
cleotides (~3 sequence of immunoglobulin enhancer as NFKB compet- 
itor, CAGAGGGGACTTTCCGAGAGG [6]) was prepared by the 
same method described above. The binding reaction was performed in 
a 15+1 mixture containing 1 pg of poly(dI-dC) poly(dI-dC) (Pharma- 
cia), 20 mM HEPES at pH 7.9, 0.1 mM EDTA, 1 mM dithiothreitol, 
10% (v/v) glycerol, 2% (w/v) polyvinyl alcohol, 2.5 pg of the nuclear 
extracts of HEL or HeLa or U937 cells. and the probe (1 x IO4 corn. 
about 25 fmol). Each antibody (1 pug) against NFiB p50‘(Santa druz 
Biotechnology), NFxB ~65 (Serotec), or c-Rel (Serotec) was added to 
the mixture for the supershift assay. The mixtures were incubated at 
room temperature for 30 min, and loaded on a 4% polyacrylamide gel. 
Electrophoresis was carried out at a constant voltage of 150 V for 2 h. 
The gel was dried, and analyzed by a Fujix Bio-image analyzer BAS 
2000. 
3. Results and discussion 
Various response elements are found in about 750 base pairs 
(bp) of the 5’-flanking region of human 12-lipoxygenase gene 
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Fig. 1. Regulatory elements of human 12-lipoxygenase gene promoter. 
Each putative consensus sequence in the 5’upstream region of human 
12-lipoxygenase gene [3] is enclosed with square. Double underline 
shows consensus sequence on the antisense strand. Abbreviations used 
are: SPl, SPl binding site; CACCC, CACCC box found in /I-globin 
gene promoters; AP2, binding site of AP2; NFKB, binding site of 
NFKB; C/EBP/3, binding site for CCAAT/enhancer-binding protein; 
and GATA, GATA box. An asterisk denotes the transcription start 
site. pl-p7 and NFKB indicate the protected regions on the sense strand 
upon DNase I footprinting analyses, and p&p10 are those on the 
antisense strand (See Fig. 4). Footprinting probes were made according 
to the sequence between two arrow heads (-618 to -416 bp). g6 and 
g7 are the EMSA probes the positions of which are indicated by broken 
line and arrows. 
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Fig. 2. Construction of luciferase expression vectors and transfection analysis of human 12-lipoxygenase gene promoter. Truncated promoter fragment 
was ligated into a luciferase plasmid. Numbers indicate distance in base pairs from the start of translation. pXLO-NFMl contains a mutant NFlcB 
motif at -539 to -530 bp (GGGACATCCC changed to GGCCCATCCC). Restriction enzyme cleavage sites and putative regulatory elements are 
also shown at the top of the figure. A mixture of each plasmrd (3 pg) and p-galactosidase plasmid (1 ,ug) was transfected into HEL cells (1.2 x lo6 
cells) by the lipofection method. The luciferase activity was normalized with the j%galactosidase activity, and expressed as units/s/IO6 cells. 
(Fig. 1). There are consensus elements for AP2 (-558 to -459 
bp and -707 to -700 bp counted from the initiation codon), 
NFicB (-539 to -530 bp), SPl (-158 to -53 bp and -594 to 
-586 bp) and CIEBP/3 (-433 to -426 bp). Two GATA boxes 
(-729 to -690 bp) and two CACCC boxes (-289 to -263 bp) 
are also found. 
For deletion analysis of the promoter region, we constructed 
luciferase vectors of various lengths covering the region from 
about -2000 to -218 bp (Fig. 2). Each vector was transfected 
to HEL cells by the lipofection method, and the luciferase 
activity was measured with the cell lysate. The luciferase activ- 
ity decreased when three positive regions (-944 to -609 bp, 
-491 to -412 bp, -348 to -218 bp) were deleted. In contrast, 
the luciferase activity increased when the negative region from 
-609 to -511 bp was absent. There were several response ele- 
ments such as SPl, AP2 and ClEBPjI in the positive regions 
mentioned above, and there were AP2 and NFlcB sites in the 
negative region (Fig. 2). 
The experimental results presented below suggest that NFKB 
is constitutively expressed in the nucleus of HEL cells, and 
binds to the corresponding site on the human 12-lipoxygenase 
gene promoter. First, NFKB motif is present at -539 to -525 
bp as illustrated in Fig. 1. Secondly, as shown in Fig. 3, two 
shifted bands (complexes c and d in lane Al) were found in 
EMSA using a probe targeting NFfcB site and the HEL cell 
nuclear extracts, and the bands were lost by the addition of 
competitor DNA ~3 (lanes A3-A5). Thirdly, further addition 
of antibodies against three subunits (NFKB ~50, ~65 and c-Rel) 
brought about new bands; bands a and b by anti-p50 (lanes A2 
and A8), band g by anti-p65 (lane A9), and band f by anti-c-Rel 
(lane AlO). Complex c became faint by the addition of anti-c- 
Rel antibody (lane AlO). NFlcB ~50 homodimer presented as 
complex e in lane B2 was different from complexes c and d. For 
further characterization of these complexes binding to NFlcB 
motif in HEL cells, nuclear extracts were also prepared from 
U937 and HeLa cells, and used in EMSA. It is known that 
NFKB and Rel proteins are expressed in the nuclei of HeLa and 
U937 cells [21,22]. When these nuclear extracts were added, the 
complex d appeared (lanes C2 and C3). When the amounts of 
nuclear extracts were doubled to 5 pug, complex h appeared 
(lanes C5-C7). Furthermore, c-Rel protein is 75 kDa which is 
a little bigger than ~65 (65 kDa). Thus, complex h is presumably 
a heterodimer of c-Rel and ~50. Since NFlcB motif was identi- 
fied first as an enhancer of immunoglobulin K light-chain gene, 
we end-labeled ~3 double-stranded oligonucleotides and used 
them as probes in EMSA for our 12-lipoxygenase gene. As 
shown in Fig. 3D, complex /I was found using the three nuclear 
extracts, and complex a appeared using HEL and U937 cell 
nucelar extracts (lanes D llD3). Complexes a and /I were differ- 
ent from complex y which was an NFlcB ~50 homodimer (lane 
D4). Complex a may be a P50 and c-Rel heterodimer, and 
complex /3 is presumably a P50 and ~65 heterodimer. Thus, the 
complex d is a heterodimer of NFIcB ~50 and ~65, and complex 
h is a NFKB ~50 and c-Rel heterodimer. It is known that c-Rel 
protein interacts with many factors [23-271. Therefore, the 
complex c may be composed of NFKB ~50, c-Rel protein and 
other proteins interacting with c-Rel protein. In addition, muta- 
tion of the NFKB motif in the human 12-lipoxygenase gene 
increased the luciferase activity (pXLO-NFMl in Fig. 2). Using 
a site-specific mutant probe of NFfcB site (g7), complexes c and 
d were not detected (lane B4), and a much less dense band of 
complex e was observed indicating the decrease in its affinity 
(lane B5). These findings suggest a negative regulation of 12- 
lipoxygenase gene expression by complexes of proteins binding 
to NFKB motif in HEL cells. 
We also demonstrated three positive regulatory regions 
(-944 to -609 bp, -491 to -412 bp, -348 to -218 bp) by the 
luciferase assay (Fig. 2) but these regions have no known 
response elements. We prepared sense and antisense probes 
from -618 to -416 bp (Fig. 1), and used them in the foot- 
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Fig. 3. Electrophoretic mobility-shift assay. Shifted bands are indicated by arrows a-g and a-y. The nuclear extracts (2.5 fig protein) were incubated 
with each probe. (A) The HEL cell nuclear extracts and probe g6 targeting NFKB site were used. Lanes 1 and 7 were for the HEL cells nuclear extracts 
alone. ~3 competitor DNA of NFlcB site was added; 50 fmol(2-fold molar excess against g6 probe, lane 3), 1 pmol(40-fold, lane 4) 50 pmol(2000-fold, 
lane 5). Anti-NFrcB p50 (lanes 2 and 8) anti-NFnB p65 (lane 9) or anti-c-Rel (lane 10) antibodies were incubated in addition to the nuclear extracts. 
Lanes 6 and 11 were for incubation with no protein. (B) Probe g6 and probe g7 which contained a mutation for NFrcB site were used. Lanes 1 and 
4 were for the HEL cells nuclear extracts alone. For controls, 50 ng of purified NFrcB p50 protein (lanes 2 and 5) were incubated. Lanes 3 and 6 
were for incubation without proteins. (C) g6 probe was used with HEL (lanes 1 and 5), HeLa (lanes 2 and 6) and U937 (lanes 3 and 7) cell nuclear 
extracts. Nuclear extracts were incubated in an amount of 2.5 pg (lanes l-3) 5.0 pg (lanes 5-7) and none (lane 4). (D) ~3 probe was incubated with 
HEL (lane I), HeLa (lane 2) and U937 (lane 3) cell nuclear extracts; NFfcB ~50 protein (lane 4) or none (lane 5). 
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Fig. 4. DNase I footprinting analysis. Two probes (2 x lo4 cpm) were 
prepared and allowed to react with the HEL cell nuclear extracts 
(27 pg). Sense strand probe was used in lanes 2 and 3, while antisense 
strand probe was used in lanes 4, 5 and 6. Lane 1, sequencer ladders 
for sense-strand; lanes 2 and 5, with the nuclear extracts; lanes 3 and 
6, without the nuclear extracts; lane 4, G + A reaction. The protected 
regions pl_plO and NFxB sequence are shown by bars on the left side. 
printing analysis with the nuclear extracts of HEL cells (Fig. 
4). The sense probe showed DNase I protection in the regions 
of pl-p7 and NFlcB consensus sequence (lane 2), and the re- 
gions of p8-p10 in the antisense probe were also protected (lane 
5). As shown in Fig. 1, p6, p7 and p8 are found in one of the 
positive regions (-491 to -412 bp) demonstrated by luciferase 
assay. However, their binding proteins are still unidentified. It 
should be noted that p6 and p7 had the same sequence 
CCTTCCCC. A certain transcription factor binding to this 
CCTTCCCC motif may work as a positive transcriptional reg- 
ulator for human 12-lipoxygenase. 
Little is known about the transcriptional regulation of mam- 
malian lipoxygenases. Human 5-lipoxygenase gene has many 
GC-rich regions (-212 to -88 bp from the initiation codon), 
and these regions have positive regulatory elements as exam- 
ined by chloramphenicol acetyltransferase assay. Transcription 
factor SPl was bound to these regions judging from EMSA 
using HeLa cell nuclear extracts and an SPl competitor ol- 
igonucleotide [28]. The SPl may be involved in lipoxygenase 
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gene expression since SPl consensus sequences are present in 
all mammalian lipoxygenase gene promoters so far studied 
[2-5, 28-301. In addition to human 12-lipoxygenase, NFI~B 
consensus motifs were found in several mammalian lipoxygen- 
ase genes: two types of murine 12-lipoxygenase (-383 to -374 
bp in platelet-type; -485 to -476 bp and -808 to -799 bp in 
leukocyte-type) [5], and human (-445 to -436 bp) [28] and 
guinea pig (-327 to -318 bp) [29] 5-lipoxygenases. In contrast, 
the gene promoters of porcine 12-lipoxygenase and rabbit 15- 
lipoxygenase have no NFrcB motif within the sequences already 
determined [2,30]. When these NFlcB sites and their vicinity are 
compared between human and murine platelet-type 12-lipoxy- 
genase genes, we should note that there are three common 
sequences: NFfcB, GGGACATCCC (human) and GGGCAT 
CCCC (murine); AP2, CCCCAGAC (human) and CCCCAGGC 
(murine); p4 (Fig. l), GCCCTCC (human and murine) [3-51. 
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